Stefan Reuter

Muenster, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications

SGLT2 inhibitors in kidney transplant recipients: metabolic changes, potassium-related safety and implications for albuminuria assessment.

SGLT2 inhibitors in kidney transplant recipients: metabolic changes, potassium-related safety and implications for albuminuria assessment.

Journal: Frontiers in transplantation
Published: July 03, 2026

Beyond Trough Levels: Tacrolimus Dose Requirements and Individualized Monitoring in Kidney Transplantation.

Beyond Trough Levels: Tacrolimus Dose Requirements and Individualized Monitoring in Kidney Transplantation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: June 12, 2026

First-year all-cause kidney allograft loss: descriptive clinical trajectories of 92 events from a 17-year German transplant center cohort.

First-year all-cause kidney allograft loss: descriptive clinical trajectories of 92 events from a 17-year German transplant center cohort.

Journal: BMC nephrology
Published: June 09, 2026

Comment on "Drug Overdose Mortality Decline and Deceased Donor Transplantation in the United States".

Comment on "Drug Overdose Mortality Decline and Deceased Donor Transplantation in the United States".

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: June 07, 2026

Safety and efficacy of rituximab-free ABO incompatible kidney transplantation: a German multicenter cohort study.

Safety and efficacy of rituximab-free ABO incompatible kidney transplantation: a German multicenter cohort study.

Journal: Frontiers in nephrology
Published: June 03, 2026

Beyond the acceptance decision: integrating genetic findings into lifelong living donor care.

Beyond the acceptance decision: integrating genetic findings into lifelong living donor care.

Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: May 26, 2026

Comment on "The allograft survival of kidneys from living donors ≥65 years is similar to that of younger living donors in recipients ≥35 years".

Comment on "The allograft survival of kidneys from living donors ≥65 years is similar to that of younger living donors in recipients ≥35 years".

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: May 11, 2026

Comment on "Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study".

Comment on "Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study".

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: May 08, 2026

Highly sensitized kidney transplant candidates: integrating acceptable mismatch, desensitization, imlifidase, and emerging immune-cell targeting strategies.

Highly sensitized kidney transplant candidates: integrating acceptable mismatch, desensitization, imlifidase, and emerging immune-cell targeting strategies.

Journal: Frontiers in immunology
Published: April 29, 2026

Steroid pulse therapy for acute T-cell-mediated rejection after kidney transplantation: mechanisms, evidence, and unresolved questions.

Steroid pulse therapy for acute T-cell-mediated rejection after kidney transplantation: mechanisms, evidence, and unresolved questions.

Journal: Frontiers in immunology
Published: April 28, 2026

Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report.

Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus report.

Journal: Frontiers in immunology
Published: April 02, 2026

Early Tacrolimus Underexposure Predicts Acute Rejection After Renal Transplantation.

Early Tacrolimus Underexposure Predicts Acute Rejection After Renal Transplantation.

Journal: Therapeutic drug monitoring
Published: March 25, 2026
Showing 1-12 of 140

Last Updated: 09/26/2026